JBG SMITH Posts $82M Q3 Loss on $69M Impairment; Core FFO Rises to $0.22
JBGS sits 25% above its 52-week low of $9.93.
Summary
JBG SMITH's Q3 2026 net loss widened to $82.0 million on $69.2 million of impairments, but Core FFO rose to $0.22 per share and Same Store NOI grew 3.3%. October asset recapitalizations and $11.5 million of buybacks continue the recycle-capital-into-office strategy.
Key Events · Earnings and Guidance · JBGS
-
Q3 Loss Driven by Impairments
Net loss attributable to common shareholders was $82.0 million, or $1.41 per diluted share, versus $28.6 million ($0.48) in Q3 2025, including $69.2 million of impairment losses ($114.7 million for the nine months).
-
Core FFO Improves to $0.22
Core FFO attributable to common shareholders was $12.7 million, or $0.22 per diluted share, up from $9.1 million ($0.15) a year earlier; FFO was $10.4 million ($0.18).
-
Same Store NOI Up 3.3%
Same Store NOI rose 3.3% to $60.8 million and annualized NOI increased 2.9%, or $7.2 million, quarter over quarter to $256.4 million; multifamily same-store occupancy reached 93.1%, up 270 basis points.
-
Leverage at 11.6x, Improving
Net Debt to Annualized Adjusted EBITDA was 11.6x at September 30, 2026, better than 12.3x at year-end 2025, with $78.5 million of cash and $454.2 million undrawn on the revolver.
Analysis · JBGS · Real Estate & Construction
The headline loss is an accounting story, not a cash story: $69.2 million of impairment charges drove the $82.0 million net loss, while Core FFO — the metric REIT investors actually underwrite — rose to $0.22 per diluted share from $0.15 a year earlier. Operating trends are improving where it matters most: Same Store NOI up 3.3%, annualized NOI up 2.9% sequentially to $256.4 million, multifamily same-store occupancy up 270 basis points quarter over quarter, and office leasing on pace for the strongest new-leasing year since 2019. Leverage remains the pressure point at 11.6x net debt to annualized adjusted EBITDA, though that is better than 12.3x at year-end 2025 and helped by October's recapitalizations of 800 North Glebe Road (90% sold) and Dulles View (reduced to a 30% interest). The $356.1 million Wardman Tower judgment disclosed in August remains the largest unresolved risk and is not resolved by this filing.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JBGS was trading at $12.45 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $729.3M. The 52-week trading range was $9.93 to $19.02. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.